Biotech Values

[jq1234]

Different combinations. To me they just simply want to see this combo in GT1 with longer treatment duration as addon to GT3 longer treatment duration for naive study they wanted to do, nothing else. In GT3, longer treatment duration 16 weeks did produce better numerical SVR in treatment experienced than 12 weeks. If they have concern with other combo currently in pivotal trials, they would have explored different combination than simple sofosbuvir plus ribavirin combo. Longer treatment duration for this combo in GT1 wouldn't tell them anything about treatment duration for other combo.